BASF

Articles by BASF

Crystallization inhibitors maintain super saturation of free drug during the absorption window upon oral administration. Formulators can achieve this by utilizing function excipients which provide solubilization enhancement and crystallization inhibition. We recently used the inhibitors to limit precipitation of drugs during the lipolysis of SEDDS and correlated with the Vivo performance. Additionally, these functional inhibitors effectively increased drug load and improved overall bioavailability by forming supersaturated-SEDDS. This podcast will cover the role of crystallization inhibitors in formulation and how to use in SEDDS formulation effetely.

Metamorphosis of topical products describes a product’s physiochemical changes that occur immediately upon administration to human skin. How does this process impact a product’s efficacy? And how do you mimic this process in vivo and in other clinical settings?

Accelerate Time to Market via Virtual Formulation Design: A Step-By-Step Approach

*Live: Wednesday, June 23, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST* Would you like to reduce development costs and accelerate time to market? Learn how to leverage virtual formulation assistants to predict tabletability and ingredient incompatibilities while considering the impact of material properties. *On Demand Until June 23, 2022*

Latest Updated Articles